ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

In Brief: Streamlining Of Contract Award Process Still Top Priority At NCI; Training Grants No Closer

January 10, 1975

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

ASCO, AACR Honor Scientists, Journalists At Annual Meetings

May 29, 1992

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993